ArticleFrontiers in behavioral neuroscience2023

Novel EAAT2 activators improve motor and cognitive impairment in a transgenic model of Huntington's disease.

Akanksha Bhatnagar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.